Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention

Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic compli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dimitrios Alexopoulos, Charalampos Varlamos, Despoina-Rafailia Benetou
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/7cd2d99bafad4623b7befa5181ab0d7c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7cd2d99bafad4623b7befa5181ab0d7c
record_format	dspace
spelling	oai:doaj.org-article:7cd2d99bafad4623b7befa5181ab0d7c2021-12-04T16:03:45ZType and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention10.15420/usc.2020.131758-390X1758-3896https://doaj.org/article/7cd2d99bafad4623b7befa5181ab0d7c2020-11-01T00:00:00Zhttps://www.uscjournal.com/articles/type-and-duration-of-dual-antiplatelet-therapyhttps://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XComplex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic complications are hindered by a concomitant increase in bleeding rates. The aim of this article is to describe ischemic and bleeding outcomes associated with complex PCI procedures and to compare different types and durations of DAPT regimens in terms of safety and efficacy outcomes. Issues concerning special patient groups, such as those with left main, chronic total occlusion, or bifurcation lesions, are discussed.Dimitrios AlexopoulosCharalampos VarlamosDespoina-Rafailia BenetouRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 14, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Dimitrios Alexopoulos Charalampos Varlamos Despoina-Rafailia Benetou Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
description	Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic complications are hindered by a concomitant increase in bleeding rates. The aim of this article is to describe ischemic and bleeding outcomes associated with complex PCI procedures and to compare different types and durations of DAPT regimens in terms of safety and efficacy outcomes. Issues concerning special patient groups, such as those with left main, chronic total occlusion, or bifurcation lesions, are discussed.
format	article
author	Dimitrios Alexopoulos Charalampos Varlamos Despoina-Rafailia Benetou
author_facet	Dimitrios Alexopoulos Charalampos Varlamos Despoina-Rafailia Benetou
author_sort	Dimitrios Alexopoulos
title	Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
title_short	Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
title_full	Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
title_fullStr	Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
title_full_unstemmed	Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
title_sort	type and duration of dual antiplatelet therapy in complex percutaneous coronary intervention
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/7cd2d99bafad4623b7befa5181ab0d7c
work_keys_str_mv	AT dimitriosalexopoulos typeanddurationofdualantiplatelettherapyincomplexpercutaneouscoronaryintervention AT charalamposvarlamos typeanddurationofdualantiplatelettherapyincomplexpercutaneouscoronaryintervention AT despoinarafailiabenetou typeanddurationofdualantiplatelettherapyincomplexpercutaneouscoronaryintervention
_version_	1718372744941273088

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention

Ejemplares similares